Literature DB >> 23765726

The lost intrinsic fragmentation of MAT1 protein during granulopoiesis promotes the growth and metastasis of leukemic myeloblasts.

Siyue Lou1, Gang Liu, Hiroyuki Shimada, Xiaochun Yang, Qiaojun He, Lingtao Wu.   

Abstract

MAT1, an assembly factor and targeting subunit of both cyclin-dependent kinase-activating kinase (CAK) and general transcription factor IIH (TFIIH) kinase, regulates cell cycle and transcription. Previous studies show that expression of intact MAT1 protein is associated with expansion of human hematopoietic stem cells (HSC), whereas intrinsically programmed or retinoic acid (RA)-induced MAT1 fragmentation accompanies granulocytic differentiation of HSC or leukemic myeloblasts. Here we determined that, in humanized mouse microenvironment, MAT1 overexpression resisted intrinsic MAT1 fragmentation to sustain hematopoietic CD34+ cell expansion while preventing granulopoiesis. Conversely, we mimicked MAT1 fragmentation in vitro and in a mouse model by overexpressing a fragmented 81-aa MAT1 polypeptide (pM9) that retains the domain for assembling CAK but cannot affix CAK to TFIIH-core. Our results showed that pM9 formed ΔCAK by competing with MAT1 for CAK assembly to mimic MAT1 fragmentation-depletion of CAK. This resulting ΔCAK acted as a dominant negative to inhibit the growth and metastasis of different leukemic myeloblasts, with or without RA resistance, by concurrently suppressing CAK and TFIIH kinase activities to inhibit cell cycle and gene transcription. These findings suggest that the intrinsically programmed MAT1 expression and fragmentation regulate granulopoiesis by inversely coordinating CAK and TFIIH activities, whereas pM9 shares a mechanistic resemblance with MAT1 fragmentation in suppressing myeloid leukemogenesis. © AlphaMed Press.

Entities:  

Keywords:  C-terminal fragmentation of MAT1; CAK-coordinated cell cycle and transcription; Myeloid leukemia; Retinoid signaling; Transcription factor IIH kinase

Mesh:

Substances:

Year:  2013        PMID: 23765726      PMCID: PMC3795903          DOI: 10.1002/stem.1444

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  53 in total

1.  RNA antisense abrogation of MAT1 induces G1 phase arrest and triggers apoptosis in aortic smooth muscle cells.

Authors:  L Wu; P Chen; J J Hwang; L W Barsky; K I Weinberg; A Jong; V A Starnes
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

Review 2.  The cdk-activating kinase (CAK): from yeast to mammals.

Authors:  P Kaldis
Journal:  Cell Mol Life Sci       Date:  1999-02       Impact factor: 9.261

3.  AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia.

Authors:  W Jin; K Wu; Y-Z Li; W-T Yang; B Zou; F Zhang; J Zhang; K-K Wang
Journal:  Oncogene       Date:  2012-05-28       Impact factor: 9.867

Review 4.  Regulation of azurophil granule-associated serine protease genes during myelopoiesis.

Authors:  J L Grisolano; T J Ley
Journal:  Curr Opin Hematol       Date:  1996-01       Impact factor: 3.284

5.  CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment.

Authors:  D J Park; A M Chumakov; P T Vuong; D Y Chih; A F Gombart; W H Miller; H P Koeffler
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

6.  Osteolineage niche cells initiate hematopoietic stem cell mobilization.

Authors:  Shane R Mayack; Amy J Wagers
Journal:  Blood       Date:  2008-05-02       Impact factor: 22.113

Review 7.  Retinoic acid receptors, hematopoiesis and leukemogenesis.

Authors:  Steven J Collins
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

8.  Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.

Authors:  G Guenechea; J C Segovia; B Albella; M Lamana; M Ramírez; C Regidor; M N Fernández; J A Bueren
Journal:  Blood       Date:  1999-02-01       Impact factor: 22.113

9.  Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation.

Authors:  Anxun Wang; Irina N Alimova; Peihua Luo; Ambrose Jong; Timothy J Triche; Lingtao Wu
Journal:  FASEB J       Date:  2009-11-16       Impact factor: 5.191

10.  Requirement of TFIIH kinase subunit Mat1 for RNA Pol II C-terminal domain Ser5 phosphorylation, transcription and mRNA turnover.

Authors:  Katja Helenius; Ying Yang; Timofey V Tselykh; Heli K J Pessa; Mikko J Frilander; Tomi P Mäkelä
Journal:  Nucleic Acids Res       Date:  2011-03-08       Impact factor: 16.971

View more
  10 in total

Review 1.  Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Authors:  Hisham Abdel-Azim; Weili Sun; Lingtao Wu
Journal:  Pharmacol Ther       Date:  2019-08-27       Impact factor: 12.310

2.  GC7 blocks epithelial-mesenchymal transition and reverses hypoxia-induced chemotherapy resistance in hepatocellular carcinoma cells.

Authors:  Qing-Yun Zhou; Chao-Yong Tu; Chu-Xiao Shao; Wu-Ke Wang; Jing-De Zhu; Ying Cai; Jia-Yan Mao; Wei Chen
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

3.  Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortality.

Authors:  Lin Li; Xiaotian Qi; Weili Sun; Hisham Abdel-Azim; Siyue Lou; Hong Zhu; Nemani V Prasadarao; Alice Zhou; Hiroyuki Shimada; Koichi Shudo; Yong-Mi Kim; Sajad Khazal; Qiaojun He; David Warburton; Lingtao Wu
Journal:  EMBO Mol Med       Date:  2016-11-02       Impact factor: 12.137

4.  MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance.

Authors:  Shan Zhou; Jinping Lu; Yuejin Li; Chan Chen; Yongqiang Cai; Gongjun Tan; Zhengke Peng; Zhenlin Zhang; Zigang Dong; Tiebang Kang; Faqing Tang
Journal:  J Exp Clin Cancer Res       Date:  2018-11-26

5.  MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway.

Authors:  Chensheng Qiu; Weiliang Su; Nana Shen; Xiaoying Qi; Xiaolin Wu; Kai Wang; Lin Li; Zhu Guo; Hao Tao; Guanrong Wang; Bohua Chen; Hongfei Xiang
Journal:  BMC Cancer       Date:  2020-12-03       Impact factor: 4.430

6.  Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin.

Authors:  Hong Zhu; Peihua Luo; Yingying Fu; Jincheng Wang; Jiabin Dai; Jinjin Shao; Xiaochun Yang; Linlin Chang; Qinjie Weng; Bo Yang; Qiaojun He
Journal:  Oncotarget       Date:  2015-02-20

7.  Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells.

Authors:  Xiao-Yang Dai; Lin-Han Zhuang; Dan-Dan Wang; Tian-Yi Zhou; Lin-Lin Chang; Ren-Hua Gai; Di-Feng Zhu; Bo Yang; Hong Zhu; Qiao-Jun He
Journal:  Oncotarget       Date:  2016-02-09

8.  The HER2 inhibitor TAK165 Sensitizes Human Acute Myeloid Leukemia Cells to Retinoic Acid-Induced Myeloid Differentiation by activating MEK/ERK mediated RARα/STAT1 axis.

Authors:  Xuejing Shao; Yujia Liu; Yangling Li; Miao Xian; Qian Zhou; Bo Yang; Meidan Ying; Qiaojun He
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

9.  LEON-BIS: multiple alignment evaluation of sequence neighbours using a Bayesian inference system.

Authors:  Renaud Vanhoutreve; Arnaud Kress; Baptiste Legrand; Hélène Gass; Olivier Poch; Julie D Thompson
Journal:  BMC Bioinformatics       Date:  2016-07-07       Impact factor: 3.169

10.  MAT1 correlates with molecular subtypes and predicts poor survival in breast cancer.

Authors:  Hanxiao Xu; Xianguang Bai; Shengnan Yu; Qian Liu; Richard G Pestell; Kongming Wu
Journal:  Chin J Cancer Res       Date:  2018-06       Impact factor: 5.087

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.